Review Highlights Deep Learning Gaps in Drug-Target Prediction

This paper provides a thorough review and comparative analysis of recent deep learning approaches used for predicting drug-target binding affinity, a crucial step in computational drug discovery. The authors examine various neural network architectures and representation strategies, assessing their performance on common benchmark datasets and evaluation metrics. While many reviewed methods report impressive results on standard benchmarks, the analysis reveals significant underlying issues. The effectiveness of these methods is frequently influenced by biases within the datasets and the limitations of current evaluation settings. A particular challenge highlighted is the reduced performance of most methods in "cold-start" scenarios, where new drugs or targets are introduced, indicating poor generalization capabilities. The review identifies several key limitations, including dataset imbalance, a lack of standardized evaluation protocols, and restricted real-world applicability. Future research directions are proposed, focusing on the need for improved dataset design, more robust evaluation methods, better handling of cold-start problems, and the integration of multimodal representations to enhance prediction accuracy and generalizability.